ATORVASTATINE ALMUS PHARMA 10 mg, comprimé pelliculé — plaquette(s) PVC polyéthylène PVDC aluminium de 90 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930169926
  • CIP7 3016992
  • CIS 60519117

What the source publishes

Holder
ALMUS FRANCE
Active ingredients
ATORVASTATINE, ATORVASTATINE CALCIQUE TRIHYDRATÉE
Form
comprimé pelliculé
Package
plaquette(s) PVC polyéthylène PVDC aluminium de 90 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration de commercialisation
Authorised on
2019-01-14
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930169926
{
  "cis": "60519117",
  "cip7": "3016992",
  "form": "comprimé pelliculé",
  "name": "ATORVASTATINE ALMUS PHARMA 10 mg, comprimé pelliculé — plaquette(s) PVC polyéthylène PVDC aluminium de 90 comprimé(s)",
  "cip13": "3400930169926",
  "holder": "ALMUS FRANCE",
  "routes": [
    "orale"
  ],
  "holders": [
    "ALMUS FRANCE"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "11.80",
  "authorisedOn": "2019-01-14",
  "compositions": [
    {
      "name": "ATORVASTATINE",
      "nature": "FT",
      "strength": "10 mg",
      "linkageNumber": "1",
      "substanceCode": "19809",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "ATORVASTATINE CALCIQUE TRIHYDRATÉE",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "92464",
      "dosageReference": null,
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "2.76",
  "medicinePrice": "9.04",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "ATORVASTATINE ALMUS PHARMA 10 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) PVC polyéthylène PVDC aluminium de 90 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65%"
  ],
  "marketingDeclaredOn": "2020-01-21",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "ATORVASTATINE",
    "ATORVASTATINE CALCIQUE TRIHYDRATÉE"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930169926"